Insider filing
Traded Jan 2 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 30, 2025 · Filed Dec 30, 2025
A Mustang Bio director paid $238 out of pocket for Mustang Bio shares. Shares held went up 633% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$238
Shares × reported transaction price
<$25K
+633.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $0.95 on Dec 30, 2025, at its 52-week low, after a 22% drop over the previous 30 trading days
52-week range $0.95 (Dec 30, 2025) to $12.83 (Jan 10, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $1.22 on Nov 14, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any MBIO insider since Sep 2022. David Jin's first open-market purchase of MBIO in filings since 2018
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +15.2% | +1.1% | +14.1% |
| 30 days | −1.6% | +1.5% | −3.1% |
| 90 days | −25.8% | −4.6% | −21.2% |
| 180 days | −28.7% | +8.7% | −37.4% |
Past results only. Not a forecast.
Insider filing
Traded Jan 2 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider selling
Traded Dec 30, 2025 · filed the same dayNot reported under a pre-arranged trading plan
A Mustang Bio director sold $238 of Mustang Bio shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 30, 2025 · filed the same dayNot reported under a pre-arranged trading plan
A Mustang Bio director sold $4 of Mustang Bio shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.